OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 33 citing articles:

Molecular and Cellular Mechanisms of Propolis and Its Polyphenolic Compounds against Cancer
Nada Oršolić, Maja Jazvinšćak Jembrek
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10479-10479
Open Access | Times Cited: 55

Polyphenol-Loaded Nano-carriers for Breast Cancer Therapy: A Comprehensive Review
Asif Ahmad Bhat, Gaurav Gupta, Muhammad Afzal, et al.
BioNanoScience (2024) Vol. 14, Iss. 4, pp. 4219-4237
Closed Access | Times Cited: 10

Towards dual function of autophagy in breast cancer: A potent regulator of tumor progression and therapy response
Mehrdad Hashemi, Mahshid Deldar Abad Paskeh, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114546-114546
Open Access | Times Cited: 19

Ginsenoside Rg5 inhibits glioblastoma by activating ferroptosis via NR3C1/HSPB1/NCOA4
Guoqing Zhang, Jinpeng Hu, Ao Li, et al.
Phytomedicine (2024) Vol. 129, pp. 155631-155631
Closed Access | Times Cited: 5

Naringenin as a potential inhibitor of human cyclin-dependent kinase 6: Molecular and structural insights into anti-cancer therapeutics
Mohd Yousuf, Anas Shamsi, Shama Khan, et al.
International Journal of Biological Macromolecules (2022) Vol. 213, pp. 944-954
Open Access | Times Cited: 18

Naringenin as potent anticancer phytocompound in breast carcinoma: from mechanistic approach to nanoformulations based therapeutics
Deena Elsori, Pratibha Pandey, Seema Ramniwas, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3

Immune-inflammatory modulation by natural products derived from edible and medicinal herbs used in Chinese classical prescriptions
Qianming Kang, Luying He, Yang Zhang, et al.
Phytomedicine (2024) Vol. 130, pp. 155684-155684
Closed Access | Times Cited: 2

Integrated analysis of FKBP1A/SLC3A2 axis in everolimus inducing ferroptosis of breast cancer and anti-proliferation of T lymphocyte
Zihan Chen, Rongxue Li, Min Fang, et al.
International Journal of Medical Sciences (2023) Vol. 20, Iss. 8, pp. 1060-1078
Open Access | Times Cited: 5

Unraveling molecular similarities between colorectal polyps and colorectal cancer: a systems biology approach
Mehran Radak, Hossein Fallahi
Intestinal Research (2024) Vol. 22, Iss. 2, pp. 199-207
Open Access | Times Cited: 1

Mechanisms underlying the therapeutic effects of Xiaoyaosan in treating hyperplasia of mammary glands based on network pharmacology
Peizhe Li, Yuxing Tai, Long Zhang, et al.
Medicine (2024) Vol. 103, Iss. 12, pp. e36263-e36263
Open Access | Times Cited: 1

Pan-cancer analysis of the prognostic and immunological role of FKBP4
Hanchu Xiong, Zihan Chen, Yucheng Li, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e29098-e29098
Open Access | Times Cited: 1

Genome-wide analysis of UDP-glycosyltransferase family in Citrus sinensis and characterization of a UGT gene encoding flavonoid 1–2 rhamnosyltransferase
Jing Chen, Xiaojun Qiu, Zhimin Sun, et al.
International Journal of Biological Macromolecules (2024), pp. 135752-135752
Closed Access | Times Cited: 1

Hsa_circ_0128846 knockdown attenuates the progression of pancreatic cancer by targeting miR-1270/NR3C1 axis
Ming Wang, Ming Li, Zehan Liu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3

SHMT as a Potential Therapeutic Target for Renal Cell Carcinoma
Yongli Situ, Juying Zhang, Wenyu Liao, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 9
Open Access | Times Cited: 3

Impact of FKBP52 on cell proliferation and hormone‐dependent cancers
Shunsuke Hanaki, Midori Shimada
Cancer Science (2023) Vol. 114, Iss. 7, pp. 2729-2738
Open Access | Times Cited: 2

Personalized differential expression analysis in triple-negative breast cancer
Hao Cai, Liangbo Chen, Shuxin Yang, et al.
Briefings in Functional Genomics (2024) Vol. 23, Iss. 4, pp. 495-506
Closed Access

Targeting Myeloid Determinants of Breast Cancer
Chie Kudo‐Saito, Yukinori Ozaki
(2024), pp. 255-285
Closed Access

From Pathological Mechanisms to Therapeutic Potential: Naringenin in the Treatment of Gonfh
Huihui Xu, Haipeng Huang, Kaiao Zou, et al.
(2024)
Closed Access

SETBP1 activation upon MDM4-enhanced ubiquitination of NR3C1 triggers dissemination of colorectal cancer cells
Peng Zhai, Heng Zhang, Qiang Li, et al.
Clinical & Experimental Metastasis (2024) Vol. 41, Iss. 5, pp. 747-764
Closed Access

Page 1 - Next Page

Scroll to top